MA 104 cells, inoculated with parainfluenza 3 virus, strain III v 2932.
Several centrifugation steps including sucrose gradient.
STE, 0.09 % sodium azide (NaN₃), 0.005 % thimerosal
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Purity > 90 %
Serology studies such as indirect EIA, hemagglutinin inhibition test, complement fixation test.
-20 °C (-15 … -30 °C allowed)
This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains thimerosal and sodium azide as a preservative. Although the amounts are very small appropriate care must be taken when handling this product.